OraSure Technologies (OSUR) vs Sanara MedTech (SMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
OraSure Technologies (OSUR) has outperformed Sanara MedTech (SMTI) over the past year, gaining 17.1% versus a gain of 8.4%. Over five years, SMTI leads with a +6.3% price change compared with -63.9% for OSUR. Sanara MedTech is the larger company by market cap ($322.1 million vs $269.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OSUR | SMTI |
|---|---|---|
| Share price | $3.91 | $35.06 |
| Market cap | $269.67M | $322.09M |
| 1-day change | +3.03% | +0.01% |
| YTD return | +56.82% | +50.11% |
| 1-year return | +17.13% | +8.41% |
| 5-year return | -63.89% | +6.28% |
| Forward P/E | — | 64.92 |
| EPS (TTM) | $-0.69 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.58 | $35.34 |
| 52-week low | $2.08 | $16.05 |
| Distance from 52-week high | -14.63% | -0.81% |
| Analyst consensus | none | none |
| Avg. price target upside | +2.30% | -0.16% |
| Average volume | 484.72K | 280.40K |
| Shares outstanding | 68.97M | 9.19M |
| Employees | 500 | 108 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About OraSure Technologies
OSUR stock →OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Health Care · Medical/Dental Instruments · 500 employees
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Health Care · Industrial Specialties · 108 employees
OSUR vs SMTI FAQ
Which is bigger, OraSure Technologies or Sanara MedTech?
Sanara MedTech (SMTI) is larger, with a market capitalization of $322.09M compared with $269.67M for OraSure Technologies (OSUR).
Which stock has performed better over the past year, OSUR or SMTI?
OSUR returned +17.13% over the past 12 months, compared with +8.41% for SMTI (price return, excluding dividends). Past performance does not predict future results.
Are OraSure Technologies and Sanara MedTech in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for OraSure Technologies and Industrial Specialties for Sanara MedTech.